Primary percutaneous coronary intervention for ST elevation myocardial infarction: performance with focus on

Gary S H Cheung1, K L Tsui, C C Lau

  • 1Department of Medicine, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong Kong. garycsh@hotmail.com

Insights

Implementing a new management program significantly reduced door-to-treatment times for ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. This improvement highlights the effectiveness of organized clinical pathways in delivering timely reperfusion therapy.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • ST elevation myocardial infarction (STEMI) requires rapid reperfusion therapy.
  • Primary percutaneous coronary intervention (PCI) is the preferred treatment for STEMI.
  • Door-to-treatment time is a critical metric for STEMI management.

Purpose of the Study:

  • To evaluate the impact of a new management program on door-to-treatment times for primary PCI in STEMI patients.
  • To assess the performance of a primary PCI program in a regional hospital setting.

Main Methods:

  • Retrospective study of STEMI patients undergoing primary PCI.
  • Data collected from January 2002 to December 2007.
  • Analysis focused on door-to-balloon times before and after November 2003.

Main Results:

  • A total of 209 STEMI patients underwent primary PCI.
  • The mean door-to-balloon time decreased from 146 to 116 minutes after program implementation (P=0.047).
  • Common delays included diagnostic delays (28%) and Cath Lab occupancy (20%).

Conclusions:

  • The primary PCI program demonstrated satisfactory performance in providing timely reperfusion for STEMI.
  • A systematic clinical pathway is essential for effective primary PCI services.
  • Enhanced public and provider awareness is needed to improve STEMI outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...